跳至主要内容
临床试验/NCT01997203
NCT01997203终止3 期

Effect of Long-term Vitamin D Therapy on IL-6, Visfatin and Hyaluronic Acid in Hepatitis C Virus Patients' Assessment

Dr. Nadia AbdelAaty AbdelKader2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
终止
发起方
入组人数
100
试验地点
2
主要终点
composite measures of Vitamin D, IL-6, Visfatin and Hyaluronic acid in Hepatitis C Virus Patients under antiviral therapy

研究概览

简要总结

Treatment of hepatitis C virus (HCV) infection was carried out using pegylated interferon (PEG-IFN), ribavirin (RBV) and vitamin D (vit D) for 48 weeks in HCV genotypes 4a subjects. The purpose of this study is to determine the effect of vitamin D on liver affection in such patients.

详细描述

Fifty patients study group administered vit D were compared with 50 patients control group without vit D. The results showed a significant elevation in vit D levels during the time period, and significant reduction on HCV RNA from the 12th wk to reach zero level in 24th wk. Interleukin 6 (IL-6), visfatin and hyaluronic acid levels were reduced significantly to reach normal values. These concentrations reduction by the effect of vit D on HCV indicated the reduction in inflammation, infection and liver cirrhosis and nearly amelioration HCV.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic HCV infection (positive HCV Ab more than 6 months)
  • Treated with pegylated interferon and ribavirin

排除标准

  • Coinfection with Hepatitis B or Hepatitis D or Human Immunodeficiency Virus
  • Previous non response to antiviral therapy.
  • Other causes of chronic liver diseases as schistosomiasis, Wilson disease and alcoholic liver disease.

研究组 & 干预措施

HCV patients under treatment

Experimental

Fifty patients study group administered vitamin D were compared with 50 patients control group without vitamin D.

Dose of vitamin D 15,000 IU/week

干预措施: Vitamin D (Drug)

结局指标

主要结局

composite measures of Vitamin D, IL-6, Visfatin and Hyaluronic acid in Hepatitis C Virus Patients under antiviral therapy

时间窗: 48 weeks

次要结局

未报告次要终点

研究者

发起方
Dr. Nadia AbdelAaty AbdelKader
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Nadia AbdelAaty AbdelKader

Ass. prof. Tropical Medicine - Ain Shams University

Ain Shams University

研究点 (2)

Loading locations...

相似试验